BioWorld Asia

Oct. 3, 2007

Franco-American Alliance Targets Hemophilia Market

LILLE, France - At least one player in France has the muscle to swim against the tide in biotechnology financings and buy into an American firm to achieve its strategic goals - the French government. (BioWorld International) Read More

European Sentiment On Biotech Remains Positive

Parasite With Minimalist Genome May Offer Clues To Metabolism

Frova Rejection By FDA Leaves Partners Annoyed

New Acambis CEO Vows To Revitalize Its Pipeline

Other News To Note

Test for Immune Response Lowers Clinical Stage Risk

DBV And Numico Extend Their Allergy Pact Globally

Austrianova Sets Up Shop In Singapore

Today's news in brief

BioWorld

BioWorld briefs for Dec. 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 29, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...